Objective: To assess the association of anxiety after myocardial infarction (MI) with cardiac prognosis. Methods: A meta-analysis of references derived from MEDLINE, EMBASE, and PSYCINFO (1975-March 2009) was performed without language restrictions. End point was cardiac outcome defined as all-cause mortality, cardiac mortality, and cardiac events. The authors selected prospective studies with at least 6 months follow-up, and anxiety had to be assessed within 3 months after MI with reliable and valid instruments. Results: Twelve papers met selection criteria. These studies described follow-up (on average, 2.6 years) of 5750 patients with MI. Anxious patients were at risk of adverse events (odds ratio (OR) fixed, 1.36; 95% confidence interval (CI), 1.18 -1.56; p Ͻ .001). Anxiety was also specifically associated with all-cause mortality (OR fixed, 1.47; 95% CI, 1.02-2.13; p ϭ .04), cardiac mortality (OR fixed, 1.23; 95% CI, 1.03-1.47; p ϭ .02), and new cardiac events (OR fixed, 1.71; 95% CI, 1.31-2.23; p Ͻ .001). Conclusions: Post-MI anxiety is associated with a 36% increased risk of adverse cardiac outcomes in bivariate analyses. Because the existing literature is small and contains several limitations, more research is needed to evaluate the association of anxiety and prognosis in patients with MI and to assess the extent to which this association is independent of clinical variables, such as disease severity, and other psychological variables, especially depression.
INTRODUCTION
C ardiovascular disease and, in particular, acute myocardial infarction (MI) is one of the leading causes of morbidity and mortality in industrialized countries (1, 2) . Several meta-analyses indicated depression as a risk factor for the development of coronary heart disease (CHD) in the general population (3, 4) and as a prognostic risk factor in post-MI patients (5) . In contrast, anxiety is a negative emotion on which much less research has focused. Although anxiety is often comorbid with depression, it is a distinct emotion (6) . Studies (7, 8) in healthy populations have demonstrated that anxiety is significantly related to the development of CHD. In addition, anxiety is very common in patients with MI, with an inhospital occurrence rate of 30% to 40% (9 -11) . Anxiety has been found to be predictive of disability, increased physical symptoms, worse functional status, and worse quality of life in patients with CHD (12) (13) (14) .
The role of anxiety regarding cardiac prognosis is unclear. Several studies in patients with CHD have shown that anxiety is related to adverse cardiac outcomes, defined as fatal and nonfatal cardiac events and inhospital ischemic and arrhythmic complications (15) (16) (17) (18) (19) . However, others did not find a relationship between anxiety and cardiac and all-cause mortality (20 -23) or even found a protective impact of anxiety on all-cause death, recurrent MI, and revascularization (24, 25) . Moreover, one study (26) showed that, when entering both anxiety and depression in a single prediction model, the effects of depression were explained away by those of anxiety, but this finding was not confirmed by other studies (27) .
Therefore, the present paper focuses on anxiety as a predictor of medical prognosis after MI. To our knowledge, this is the first meta-analysis on the prognostic association of anxiety in heart disease patients with medical outcome. The objective of this study was to investigate the association of anxiety after MI with all-cause death, cardiac death, and cardiac events and to assess this association in the light of available covariates.
METHODS Aim
To identify all studies that were available by March 2009, comparing cardiac prognosis of anxious and nonanxious patients with MI. Systematic identification, appraisal, synthesis, statistical aggregation, and reporting of results resembled known guidelines (28, 29 ).
1. Studies should contain patients who were hospitalized for acute MI. 2. Anxiety (nonphobic) had to be measured within 3 months of hospitalization for acute MI, using reliable and validated instruments to assess anxiety (either self-report or interview-based). 3. Studies had to be prospective in nature with at least 6 months' follow-up and end points had to contain: all-cause mortality, cardiac mortality, and/or cardiac events (e.g., hospitalization for unstable angina pectoris (UA), revascularization) in combination with mortality and/or recurrent MI, using a reliable and valid assessment strategy. 4. Studies had to present original data (e.g., reviews and editorials were excluded).
During the selection procedure, in case of disagreement between the two independent raters, the four investigators discussed the difference of opinion until consensus was reached. Regarding multiple reports on the same data set, only one paper was included based on end point and follow-up period, preferring hard medical end points (e.g., mortality) and longer follow-up periods. Two studies presented an analysis on a combined sample of patients with MI and UA, and we also included these studies (18, 30) . Data derived from patients randomized to placebo from a blind, placebo-controlled, medication trial in which anxiety was measured as part of an ancillary study, were included (31) . If necessary, the coordinators of the eligible studies were asked for details.
The following aspects of methodological quality were evaluated: sample size, study population (e.g., did the researchers include specific in-/exclusion criteria, such as gender or disease severity), percentage lost to follow-up, follow-up duration, and multivariable adjustment. We did not weigh the contribution of each study to the meta-analysis on the basis of quality scoring, for there are no validated measures of quality and the use of subjective rating scales may lead to bias (32) .
End Point
The end point was all-cause mortality, cardiac mortality, and/or cardiac events.
Quantitative Data Synthesis
Data from all studies were pooled, using the program Comprehensive Meta-Analysis, version 2. To pool data across studies, we converted the time-related data into simple 2 ϫ 2 tables. Thus, for all studies, irrespective of the presented effect measure (i.e., odds ratio [OR] or hazard ratio [HR] ), data were converted into (unadjusted) dichotomous outcomes. Subsequently, ORs and 95% confidence intervals (CIs) were calculated. The fixed and the random effect method (REM) were used to generate summary estimates of ORs. The appropriateness to combine results was tested with the I 2 test, which shows the proportion of total variance explained by heterogeneity. If I 2 was found to be Ͻ25%, it was considered as low (33) ; variation in the results of different studies was thought to be due to chance alone (29) . In that case, we based our main conclusions on the OR reported by the fixed effect method (FEM). We provided both estimates in the Results section for the purpose of completeness.
In two studies (11, 27) , more than one measure of anxiety was included. In these cases, the most representative measure of anxiety (i.e., State Trait Anxiety Inventory [STAI]), as compared with the anxiety measures in other included studies, was chosen.
In three studies (11, 31, 34) , anxiety symptoms were presented as a continuous variable. In these cases, the number of patients above and below the established cutoff point of the anxiety scale was estimated, using the reported mean anxiety score and standard deviation based on the assumption of normal distribution. For studies using the STAI (11, 31) , a cutoff score of Ն44 was chosen. For the study of Mayou et al. (23) , the OR was calculated based on earlier information given by the author to one of the authors of the current study (P.d.J.). In two studies (9, 27) , the number of anxious and nonanxious patients in the event versus nonevent group was calculated from the given OR or HR.
The study of Pedersen et al. (35) was excluded based on the questionnaire used, namely, the Trauma Symptom Checklist, which intends to measure traumas. Moreover, one study (36) that measured anxiety before the MI was excluded.
If study outcomes were heterogeneous based on the I 2 test, the possible effects of follow-up duration, year of data collection, study population (MI versus MI and UA patients) and trait versus state anxiety would be studied. Differences in ORs between specified subgroups were assessed by comparing the pooled ORs using 2 analysis, comparing logarithms of the ORs. To evaluate the presence of publication bias, a funnel plot was constructed by plotting the effect measure against the inverse of its standard error.
Additional Information by Personal Communication
Authors of four included studies were contacted for further information on study characteristics. Michael et al. (30) confirmed that the reported end point consisted of ischemic cardiac events as verified by a cardiologist. The study of Pfiffner and Hoffmann (37) was excluded because reported survival data were imprecise and we were not able to reproduce the reported OR. The article of Legault et al. (38) was excluded. because reported data were limited and we could not compute an OR. We used the age-and gender-adjusted HR given in the paper of Frasure-Smith and Lespérance (27) to estimate the numbers of anxious and nonanxious patients in the event and nonevent group.
RESULTS
A flow diagram of the literature search is shown in Figure  1 . The agreement rates (Cohen's ) for the two steps in the selection procedure were 0.72 and 0.93, respectively, indicating good to very good consistency of judgment by raters (39) . Twelve studies met selection criteria, and study characteristics are shown in Table 1 . Fifteen analyses reported on the prespecified end point (4 on all-cause mortality, 4 on cardiac mortality, and 7 on cardiac events). These studies described follow-up (on average, 2.6 years) of 5750 patients with MI. The mean age at time of the index MI ranged from 54 years to 63 years, and 82.5% of patients was male. The proportion of MI patients with anxiety symptoms at baseline ranged from 13.4% to 59.5%. Five analyses (2 on cardiac mortality and 3 on cardiac events) reported a significant association between anxiety and prognosis in bivariate analysis. In two studies, the association was no longer significant when controlling for demographic (e.g., age, gender) and clinical (e.g., disease severity) variables. Three analyses, two reporting on the association between anxiety and cardiac mortality or recurrent MI, and one reporting on cardiac mortality, remained significant in multivariable analysis (Table 2) .
Mortality and Cardiac Events
Twelve studies reported on the combined end point. Cardiac mortality was chosen as end point in case the study reported on more than one end point. The pooled OR for all-cause and cardiac mortality and cardiac events in 1649 anxious compared with 4101 nonanxious MI patients was 1.36 (95% CI, 1.18 -1.56; p Ͻ .001) in the FEM (Fig. 2) . No heterogeneity was observed in the model (I 2 ϭ 0.00%) and, therefore, no difference in the OR given by the FEM and REM.
The pooled OR for all-cause mortality in 925 anxious compared with 2241 nonanxious MI patients was 1. 47 The influence of anxiety on prognosis varied between end points. The impact of anxiety was significantly larger for cardiac events than for cardiac mortality (p ϭ .04). The impact of anxiety on cardiac events was not significantly different from the impact on all-cause mortality (p ϭ .52).
Because the 12 studies reporting on the combined end point did not show significant heterogeneity, no further secondary analyses were conducted.
A funnel plot of selected studies on the combined outcome suggests the presence of publication bias (Fig. 3) . Further inspection of the studies divided by end point revealed a possible bias for all-cause and cardiac mortality but not for cardiac events (not shown).
DISCUSSION
This is the first meta-analysis focusing on the association of anxiety with prognosis in patients with heart disease. The results show a consistent association between anxiety and impaired prognosis after MI, with a 36% increased risk. This increased risk applies to both mortality (cardiac and all-cause) and cardiac events. Although the association between anxiety and cardiac events was significantly larger compared with that of cardiac death, these results should be interpreted with caution, because the pooled OR for cardiac death was based on only four studies. Overall, these findings support the conclusion that anxiety is associated with adverse medical outcomes after MI.
In this meta-analysis, only one study reported on anxiety disorder, namely, generalized anxiety disorder (GAD) (20) . In bivariate analysis, both self-reported symptoms and GAD were predictors of cardiac events. In multivariable analysis, only the association between GAD and prognosis remained significant. To date, there is little information about the association between different anxiety disorders and cardiac outcome. Further research on the relationship between anxiety disorders and prognosis is warranted.
There are several potential mechanisms that may help to explain the adverse association between anxiety and cardiac prognosis. Anxiety is potentially related to several pathophysiological processes in patients with MI, including arrhythmic mechanisms (42) and dysfunction of the autonomic nervous system, such as reduced baroflex cardiac control (43) and reduced heart rate variability (44) . Theoretically, it may be that anxiety has a more influential role in electrical instability rather than in atherosclerotic or vascular disease conditions. In two studies, cardiac arrest was included as end point (18, 31) . One study found a significant association between anxiety and cardiac events (including survived cardiac arrest) (18) , and the other study (31) found no association between anxiety and all-cause mortality or cardiac arrest in patients at risk of sudden death. However, both studies did not assess the association between anxiety and cardiac arrest specifically. More research is needed to assess the association of anxiety with arrhythmic mechanisms.
In addition, a behavioral pathway of depression influencing prognosis is unhealthy behavior, like less compliance, smoking, unhealthy diet, and inactivity (5). This may also hold for anxious patients. Reversely, it is possible that anxious patients seek more help from their doctors and try to improve their medical status (11) . However, Benninghoven et al. (11) found that patients with higher anxiety levels showed neither better medication compliance nor had more contact with their cardiologists. Given that some studies have found a protective effect of anxiety on outcome (25), it might be that it is anxiety in combination with nonprotective patient behavior that leads to worse prognosis, possibly due to an avoidant coping strategy (11) or social inhibition (45) . Further research regarding the behavioral and pathophysiological mechanisms responsible for the relationship between anxiety and prognosis is warranted.
The prognostic association between anxiety and prognosis after MI seems smaller than that of depression (5) but larger as compared with the effects of anger and hostility. A recent meta-analysis (46) showed that anger and hostility were associated with a 24% increased risk of poor prognosis in patients with CHD. Overall, these results show that various psychological factors, of which depression is probably the most important one, are consistently associated with adverse outcome in patients with heart disease.
It is important to assess the extent to which the association between anxiety and prognosis is independent of other clinical and psychological variables, such as depression. Studies have found rather mixed results, with some studies retaining depression (27) and others anxiety (15, 26) . In addition, anxiety and depression have a moderate-to-strong correlation (47), yet anxiety and depression also have distinctive features (47) . It is possible that anxiety and depression are both part of a larger and more stable factor influencing prognosis in patients with heart disease, like negative affectivity (47) or Type D personality (a combination of negative affectivity and social inhibition) (45) .
Somatic symptoms of depression, such as fatigue, are known to be related to disease severity (48) . In a meta-analysis on the association between depression and CHD prognosis, adjustment for left ventricular function reduced the relative risk to almost 50% (49) . On the contrary, disease severityadjusted ORs of the association between anxiety and medical prognosis after MI are only slightly or not attenuated (18, 26, 27) . This could indicate that the association between anxiety and medical outcome is less confounded by disease severity as compared with depression.
Results of this meta-analysis indicate that treatment of distressed MI patients should not focus on depression exclusively. Large intervention trials have failed to improve medical prognosis in depressed MI patients (50, 51) , perhaps because related anxiety was not treated (47) . There is a need for more behav- 
A. M. ROEST et al.
ioral medicine programs performing clinical outcomes research (52), in which various risk factors (e.g., depression, anxiety, and hostility/anger) should be targeted.
The results need to be considered in light of the study limitations. One of the most important limitations in conducting a meta-analysis is the inevitability of combining data from studies that are not equally designed. Patient samples were heterogeneous regarding gender and disease severity, and follow-up duration differed substantially across studies. However, the results of the included studies were homogeneous; it, therefore, seems that the finding of a significant prospective association between anxiety and CHD prognosis is robust.
Anxiety is a very heterogeneous emotion, and individuals may experience different kinds of anxiety symptoms. To limit heterogeneity, we excluded studies on phobia and posttraumatic stress disorder. Still, it remains unclear which aspects of anxiety contribute to cardiac outcomes. Furthermore, six studies measured anxiety, using the STAI. Research has shown that the STAI does not clearly differentiate anxiety from depression (53) . There is a need for more research into the construct of anxiety its core features, and development of new instruments. An additional limitation is the lack of temporal information about onset of anxiety. We do not know if included patients became anxious as a result of their MI or if they were already anxious before developing CHD. Although studies (8) suggested an association between anxiety and heart disease in initially healthy persons as well, more research should focus on this topic and the possible differences be- tween these groups. Another limitation is that two studies had to be excluded because of insufficient data. Of these studies, one reported a significant (37) and one reported a nonsignificant (38) effect of anxiety on outcome. Another limitation concerns the proneness of meta-analyses to publication bias. We tried to minimize important sources of publication bias by including both non-English and nonpublished work in our literature search. We found a possible publication bias for mortality, suggesting that the association between anxiety and mortality might be smaller than reported here. However, for the largest association found in this meta-analysis, namely, between anxiety and cardiac events, we did not find indications of publication bias.
Since the existing literature is small and contains several limitations, there is a need for further research into the association of anxiety and cardiac prognosis in patients with MI. In the future, when more studies are published on this subject, this meta-analysis should be brought up to date.
In summary, post-MI anxiety is consistently related to adverse cardiac events in bivariate analyses. Findings are homogeneous and reliable, although more research is needed to assess the extent to which this association is independent of other psychological and clinical variables. The association between anxiety and outcome seems less strong than it is for depression; however, it might be less confounded by disease severity. The results from this study indicate the need for future research directed to the association between anxiety and prognosis after MI, to the identification of the underlying processes by which anxiety contributes to cardiac prognosis, and to the testing of interventions to alleviate the associated risk.
